Literature DB >> 8125754

Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor.

K Unoki1, M M LaVail.   

Abstract

PURPOSE: The protective effects of three survival-promoting agents on ischemia-induced retinal injury in the rat were investigated. The agents included brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), and basic fibroblast growth factor (bFGF).
METHODS: Retinal ischemia was induced in Lewis albino rats by increasing intraocular pressure to 160 mm Hg for 90 minutes. The agents or buffer controls were injected intravitreally at different times, either before or after the ischemic insult, and the postischemic survival time was either 7 or 14 days. The degree of retinal damage was assessed from plastic-embedded sections by cytologic analysis, measurement of the thickness of several layers, and neuronal counts of the ganglion cell layer.
RESULTS: Retinal ischemia thinned and reduced cell numbers in the inner retinal layers, but not in the photoreceptor nuclear layer. Each agent transiently ameliorated the degenerative changes when it was injected 2 days before ischemia. At 7 days postischemia, the inner retinal layers were far less damaged, and more ganglion cells were present than in buffer-injected or uninjected eyes. The protective effect was no longer evident at 14 days postischemia, except in the inner nuclear layer of the BDNF-treated eyes. If a second injection of BDNF was made 5 days after the ischemic insult, then the inner retinal layers were more preserved than buffer controls at 14 days postischemia, but the survival of ganglion cells was not enhanced. A single injection of BDNF at either 1 or 3 days postischemia reduced the degree of inner retinal damage and increased the number of surviving ganglion cells over that in buffer-injected controls. (CNTF and bFGF were not studied with postischemic injections.)
CONCLUSIONS: BDNF, CNTF, and bFGF transiently protect the retina from pressure-induced ischemic injury when given 2 days before ischemia, and a second injection of BDNF given postischemically can prolong the protective effect. Moreover, protection afforded by BDNF can be seen even when applied only 1 or 3 days after the ischemic insult, although the protective effect is greater at 1 day than at 3 days postischemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8125754

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  50 in total

Review 1.  Management of inherited outer retinal dystrophies: present and future.

Authors:  N H Chong; A C Bird
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

2.  Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy.

Authors:  M M LaVail; D Yasumura; M T Matthes; K A Drenser; J G Flannery; A S Lewin; W W Hauswirth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  An immortalized, type-1 astrocyte of mesencephalic origin source of a dopaminergic neurotrophic factor.

Authors:  D M Panchision; P A Martin-DeLeon; T Takeshima; J M Johnston; K Shimoda; P Tsoulfas; R D McKay; J W Commissiong
Journal:  J Mol Neurosci       Date:  1998-12       Impact factor: 3.444

4.  Viral-mediated FGF-2 treatment of the constant light damage model of photoreceptor degeneration.

Authors:  Dana Lau; John Flannery
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

5.  Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease.

Authors:  K D Anderson; N Panayotatos; T L Corcoran; R M Lindsay; S J Wiegand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

6.  Critical role of TrkB and brain-derived neurotrophic factor in the differentiation and survival of retinal pigment epithelium.

Authors:  Z Z Liu; L Q Zhu; F F Eide
Journal:  J Neurosci       Date:  1997-11-15       Impact factor: 6.167

7.  Neuroprotection of cerebrolysin in tissue culture models of brain ischemia: post lesion application indicates a wide therapeutic window.

Authors:  E Schauer; R Wronski; J Patockova; H Moessler; E Doppler; B Hutter-Paier; M Windisch
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

Review 8.  Gene therapy in the treatment of ocular inflammation.

Authors:  K Csaky; R Nussenblatt
Journal:  Springer Semin Immunopathol       Date:  1999

9.  Immunocytochemical characterisation of proteins secreted by retinal pigment epithelium in retinas of normal and Royal College of Surgeons dystrophic rats.

Authors:  H J Sheedlo; J E Turner
Journal:  J Anat       Date:  1998-08       Impact factor: 2.610

10.  Survival of purified rat photoreceptors in vitro is stimulated directly by fibroblast growth factor-2.

Authors:  V Fontaine; N Kinkl; J Sahel; H Dreyfus; D Hicks
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.